Numinus provides update on acquisition integration and announces new client financing...

Nature Biotechnology Selects Delix Therapeutics as a Leading Biotech Start-Up

PT355 – Ifetayo Harvey – The Drug War, Caregiving, and Blue...

Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke...

Psychedelic Bulletin #118 – San Francisco ‘Decriminalizes’ Psychedelics

Braxia Scientific Launches KetaMD in Florida; First Patients Complete Initial Virtual...

Pain and Psychedelics – Reviewing a Newly Published Paper

Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment...

New Psychedelic Entactogens: Designer Drugs Produce Designer Effects

PT354 – Laura Guzmán-Dávalos – Psilocybe, Microdosing, and Multigenerational Mycology

Load more